Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caffeine | 5 | 2023 | 81 | 3.210 |
Why?
|
| Isoflurane | 8 | 2020 | 64 | 3.110 |
Why?
|
| Anesthetics, Inhalation | 5 | 2020 | 95 | 2.360 |
Why?
|
| Anesthesia, General | 5 | 2023 | 114 | 2.040 |
Why?
|
| Dexmedetomidine | 2 | 2023 | 11 | 1.830 |
Why?
|
| Anesthetics, General | 3 | 2023 | 11 | 1.540 |
Why?
|
| Central Nervous System Stimulants | 3 | 2018 | 216 | 1.430 |
Why?
|
| Anesthesia Recovery Period | 3 | 2020 | 56 | 1.330 |
Why?
|
| Propofol | 3 | 2013 | 89 | 0.940 |
Why?
|
| Anesthetics, Intravenous | 2 | 2013 | 41 | 0.860 |
Why?
|
| Reflex, Righting | 1 | 2020 | 2 | 0.780 |
Why?
|
| Rats | 8 | 2023 | 3990 | 0.690 |
Why?
|
| Citrates | 1 | 2018 | 28 | 0.670 |
Why?
|
| Delayed Emergence from Anesthesia | 1 | 2017 | 6 | 0.620 |
Why?
|
| Adenosine A2 Receptor Antagonists | 1 | 2017 | 13 | 0.610 |
Why?
|
| Synaptic Vesicles | 3 | 2012 | 32 | 0.590 |
Why?
|
| Etomidate | 3 | 2012 | 11 | 0.580 |
Why?
|
| Stress, Psychological | 1 | 2019 | 313 | 0.550 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2023 | 1219 | 0.520 |
Why?
|
| Catecholamines | 2 | 2012 | 88 | 0.500 |
Why?
|
| Synaptosomal-Associated Protein 25 | 1 | 2012 | 14 | 0.450 |
Why?
|
| Synaptotagmin I | 1 | 2012 | 16 | 0.450 |
Why?
|
| Exocytosis | 1 | 2012 | 108 | 0.430 |
Why?
|
| Synaptic Transmission | 2 | 2010 | 222 | 0.430 |
Why?
|
| Arthralgia | 1 | 2011 | 36 | 0.410 |
Why?
|
| Bupivacaine | 1 | 2011 | 45 | 0.400 |
Why?
|
| Nerve Block | 1 | 2011 | 51 | 0.390 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2011 | 111 | 0.360 |
Why?
|
| PC12 Cells | 4 | 2013 | 115 | 0.350 |
Why?
|
| Pain, Postoperative | 1 | 2011 | 240 | 0.340 |
Why?
|
| Cross-Over Studies | 2 | 2020 | 399 | 0.330 |
Why?
|
| Neurons | 3 | 2013 | 1546 | 0.320 |
Why?
|
| Animals | 9 | 2023 | 26582 | 0.300 |
Why?
|
| Chromaffin Cells | 1 | 2006 | 37 | 0.280 |
Why?
|
| Colforsin | 2 | 2017 | 74 | 0.270 |
Why?
|
| Receptors, Adrenergic | 1 | 2023 | 15 | 0.230 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2023 | 6 | 0.230 |
Why?
|
| Drug Repositioning | 1 | 2023 | 22 | 0.220 |
Why?
|
| RNA, Catalytic | 1 | 2004 | 129 | 0.220 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2011 | 1961 | 0.220 |
Why?
|
| Double-Blind Method | 2 | 2018 | 1823 | 0.200 |
Why?
|
| Respiratory Rate | 1 | 2020 | 20 | 0.190 |
Why?
|
| Models, Animal | 1 | 2020 | 263 | 0.180 |
Why?
|
| Heart Rate | 1 | 2020 | 492 | 0.160 |
Why?
|
| Triazoles | 1 | 2017 | 96 | 0.150 |
Why?
|
| Cyclic AMP | 1 | 2017 | 273 | 0.140 |
Why?
|
| Electroencephalography | 1 | 2020 | 709 | 0.140 |
Why?
|
| Pilot Projects | 1 | 2019 | 839 | 0.140 |
Why?
|
| Pyrimidines | 1 | 2017 | 370 | 0.120 |
Why?
|
| Theophylline | 1 | 2013 | 34 | 0.120 |
Why?
|
| Patch-Clamp Techniques | 2 | 2010 | 396 | 0.110 |
Why?
|
| Premedication | 1 | 2011 | 54 | 0.100 |
Why?
|
| Time Factors | 2 | 2018 | 5210 | 0.100 |
Why?
|
| Osteoarthritis, Knee | 1 | 2011 | 63 | 0.100 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 547 | 0.100 |
Why?
|
| Hippocampus | 2 | 2010 | 442 | 0.090 |
Why?
|
| Nausea | 1 | 2011 | 175 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2010 | 782 | 0.090 |
Why?
|
| Cells, Cultured | 2 | 2010 | 2818 | 0.080 |
Why?
|
| Gene Expression | 1 | 2012 | 1284 | 0.080 |
Why?
|
| Patient Satisfaction | 1 | 2011 | 455 | 0.080 |
Why?
|
| Male | 2 | 2020 | 40965 | 0.070 |
Why?
|
| Brain | 1 | 2017 | 2216 | 0.070 |
Why?
|
| Fura-2 | 1 | 2006 | 22 | 0.070 |
Why?
|
| Bicuculline | 1 | 2006 | 18 | 0.070 |
Why?
|
| GABA Antagonists | 1 | 2006 | 25 | 0.070 |
Why?
|
| GABA Agonists | 1 | 2006 | 20 | 0.070 |
Why?
|
| Receptors, GABA-A | 1 | 2006 | 32 | 0.070 |
Why?
|
| Cattle | 1 | 2006 | 376 | 0.070 |
Why?
|
| Calcium Signaling | 1 | 2006 | 129 | 0.070 |
Why?
|
| Electrophysiology | 1 | 2006 | 401 | 0.070 |
Why?
|
| Receptors, Nicotinic | 1 | 2006 | 129 | 0.070 |
Why?
|
| Calcium | 2 | 2009 | 1156 | 0.070 |
Why?
|
| Hypnotics and Sedatives | 1 | 2006 | 125 | 0.070 |
Why?
|
| Calcium Channels | 1 | 2006 | 182 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2006 | 242 | 0.060 |
Why?
|
| In Vitro Techniques | 1 | 2006 | 989 | 0.060 |
Why?
|
| Energy Transfer | 1 | 2004 | 25 | 0.060 |
Why?
|
| Circular Dichroism | 1 | 2004 | 117 | 0.060 |
Why?
|
| Fluorescence | 1 | 2004 | 102 | 0.060 |
Why?
|
| RNA | 1 | 2008 | 560 | 0.060 |
Why?
|
| Protein Folding | 1 | 2004 | 282 | 0.050 |
Why?
|
| Protein Conformation | 1 | 2004 | 881 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 6509 | 0.050 |
Why?
|
| Adult | 1 | 2018 | 25648 | 0.040 |
Why?
|
| Female | 1 | 2020 | 44532 | 0.040 |
Why?
|
| Humans | 2 | 2018 | 86643 | 0.040 |
Why?
|
| Aged | 1 | 2011 | 18415 | 0.030 |
Why?
|
| Middle Aged | 1 | 2011 | 25028 | 0.030 |
Why?
|
| Syntaxin 1 | 1 | 2009 | 8 | 0.020 |
Why?
|
| Cyclobutanes | 1 | 2009 | 7 | 0.020 |
Why?
|
| SNARE Proteins | 1 | 2009 | 26 | 0.020 |
Why?
|
| Geobacillus stearothermophilus | 1 | 2008 | 10 | 0.020 |
Why?
|
| Magnesium | 1 | 2008 | 177 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2008 | 332 | 0.020 |
Why?
|
| Base Sequence | 1 | 2008 | 2330 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 3030 | 0.010 |
Why?
|
| Mutation | 1 | 2009 | 3968 | 0.010 |
Why?
|